A medical expert discusses strategies that have successfully mitigated the economic impact of LEMS on patients and health care systems, and how a multidisciplinary approach can reduce the clinical and economic burden of LEMS on health care delivery.
In this interview, Yehuda Handelsman, MD, highlights key updates to the Diabetes, Cardiorenal, and Metabolic (DCRM) guidelines in DCRM 2.0, shaped by global collaboration and…
Sepsis is a life-threatening, heterogeneous disorder involving a dysregulated immune response to infection. Research to identify subtypes and targeted therapies for host dysregulation is ongoing.
Costs $239.00 USD, and an additional six models are planned for the future
This cross-sectional study evaluates trends and factors associated with selecting active surveillance or watchful waiting among individuals with intermediate-risk prostate cancer.
This cross-sectional study quantifies the healthspan-lifespan gap around the world, assesses sex disparities, and analyzes associations with morbidity and mortality.
Nature Methods – Hundreds of researchers collaborate on maps of the human body and the subcellular realm. As they scout out their next mapping expeditions,…
While the list of venture capital firms investing in digital health has shrunk since 2021, the most active investors continue to write checks.
Objective To analyze mortality attributed to Alzheimer’s disease among taxi drivers and ambulance drivers, occupations that demand frequent spatial and navigational processing, compared with other…
Experiments by Anthropic and Redwood Research show how Anthropic’s model, Claude, is capable of strategic deceit
Gilead Sciences will no longer provide four HIV medicines for free as part of a patient assistance program starting at the end of January.
